Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
SarkoLife: quality of life in patients undergoing multimodal soft tissue sarcoma treatment.
World J Surg Oncol
January 2025
Department of Hand, Plastic, Reconstructive and Burn Surgery, BG Trauma Center Tuebingen, University of Tuebingen, Schnarrenbergstraße 95, Tuebingen, 72076, Germany.
Objective: To assess the tolerability of multimodal therapy in soft tissue sarcoma patients, particularly with regard to their quality of life and level of distress.
Materials And Methods: A retrospective cohort study enrolled individuals receiving sarcoma therapy at the sarcoma center of the University of Tuebingen between 2017 and 2022. Participants completed an online survey that included the EORTC's questionnaire (QLQ-C30), coupled with the distress thermometer and demographic inquiries.
Swallowing, speech and voice impairments in head and neck cancer patients treated at a multidisciplinary integrated patient unit.
Int J Lang Commun Disord
December 2024
Hearing, Speech & Language Center, Sheba Medical Center, Tel Hashomer, Israel.
Background: Head and neck cancer (HNC) is amongst the 10 most common cancers worldwide and has a major effect on patients' quality of life. Given the complexity of this unique group of patients, a multidisciplinary team approach is preferable. Amongst the debilitating sequels of HNC and/or its treatment, swallowing, speech and voice impairments are prevalent and require the involvement of speech-language pathologists (SLPs).
View Article and Find Full Text PDFImpact of Treatment Strategies on Survival and Within Multivariate Predictive Model for Renal Cell Carcinoma Based on the SEER Database: A Retrospective Cohort Study.
J Invest Surg
December 2024
Department of Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Background: This project aims to shed light on how various treatment approaches affect RCC patients' chances of survival and create a prediction model for them.
Methods: Data from the Surveillance, Epidemiology, and End Results database were used in this investigation. OS and RCSS after radiation, chemotherapy, and surgery were investigated using the Kaplan-Meier approach.
Minimally invasive interventional guided imaging therapies of musculoskeletal tumors.
Quant Imaging Med Surg
November 2024
Department of Radiology, MSK Unit, The Clinical Diagnostic Imaging Centre (CDIC), Hospital Clinic, Universitat de Barcelona (UB), Barcelona, Spain.
Article Synopsis
- Historically, musculoskeletal (MSK) tumors have been treated separately, but the complications from metastases, like pain and fractures, require a team of experts to decide on the best treatments, including surgery, radiation, or chemotherapy.
- * Recently, minimally invasive interventional therapies, particularly image-guided ablation techniques, have gained traction as promising options to effectively treat MSK tumors, offering less invasive alternatives.
- * Imaging methods like CT, which is preferred for its accessibility, guide these interventions, which include techniques like radiofrequency ablation and cryoablation, sometimes combined with other treatments for better tumor control.
Potential recovery of arm strength capability in a post-breast cancer treatment population: A simulation analysis.
J Biomech
December 2024
Department of Kinesiology & Health Sciences, University of Waterloo, Waterloo, ON, Canada. Electronic address:
Article Synopsis
- * This study used computer simulations to model different treatment scenarios and assess the muscle forces involved in regaining strength through training after treatments like radiation and chemotherapy.
- * Results indicated that 70-80% of strength recovery is possible with effective retraining, improving the ability to perform daily tasks and boosting confidence, though full recovery to pre-cancer strength levels was not achieved.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!